Is investing in a vaccine developer a smart move right now?
I’ve been looking into some biotech stocks and can’t help but notice the buzz around vaccine developers lately. It seems like the industry is constantly evolving, especially with new variants and ongoing health concerns. Some of my friends think it’s a risky play given how volatile the market can be, while others are really optimistic about the future of vaccines and their role in global health.
I’m torn—on one hand, I see the potential for growth, especially if they get approval for new products. But then there’s the risk of competition and market saturation. Has anyone else dived into this space? What are your thoughts on the long-term viability of these companies? Would love to hear from those who have experience or insight!

Comments
No comments yet.